These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37038134)

  • 41. Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.
    Stauffer VL; Dodick DW; Zhang Q; Carter JN; Ailani J; Conley RR
    JAMA Neurol; 2018 Sep; 75(9):1080-1088. PubMed ID: 29813147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and feasibility of antidepressants for the prevention of migraine in adults: a meta-analysis.
    Xu XM; Yang C; Liu Y; Dong MX; Zou DZ; Wei YD
    Eur J Neurol; 2017 Aug; 24(8):1022-1031. PubMed ID: 28557171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.
    Frampton JE
    Drugs; 2012 Apr; 72(6):825-45. PubMed ID: 22468643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache.
    Bennett MH; French C; Schnabel A; Wasiak J; Kranke P; Weibel S
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD005219. PubMed ID: 26709672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of galcanezumab in patients with migraine who did not benefit from commonly prescribed preventive treatments.
    Kuruppu DK; Tobin J; Dong Y; Aurora SK; Yunes-Medina L; Green AL
    BMC Neurol; 2021 Apr; 21(1):175. PubMed ID: 33892641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of levetiracetam for migraine prophylaxis: A systematic review.
    Watkins AK; Gee ME; Brown JN
    J Clin Pharm Ther; 2018 Aug; 43(4):467-475. PubMed ID: 29781197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
    Dodick DW; Silberstein SD; Bigal ME; Yeung PP; Goadsby PJ; Blankenbiller T; Grozinski-Wolff M; Yang R; Ma Y; Aycardi E
    JAMA; 2018 May; 319(19):1999-2008. PubMed ID: 29800211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amitriptyline in migraine prophylaxis.
    Couch JR; Hassanein RS
    Arch Neurol; 1979 Nov; 36(11):695-9. PubMed ID: 508127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials.
    Tao X; Yan Z; Meng J; Wang W; Dai Q; Zhou Q; Wang Z; Wang Z
    J Headache Pain; 2022 Jan; 23(1):19. PubMed ID: 35093013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.
    Winner PK; McAllister P; Chakhava G; Ailani J; Ettrup A; Krog Josiassen M; Lindsten A; Mehta L; Cady R
    JAMA; 2021 Jun; 325(23):2348-2356. PubMed ID: 34128999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotics for secondary prevention of coronary heart disease.
    Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Childhood and Adolescent Migraine Prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, topiramate, and placebo in the prevention of childhood and adolescent migraine.
    Hershey AD; Powers SW; Coffey CS; Eklund DD; Chamberlin LA; Korbee LL;
    Headache; 2013 May; 53(5):799-816. PubMed ID: 23594025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New Developments in the Prophylactic Drug Treatment of Pediatric Migraine: What Is New in 2017 and Where Does It Leave Us?
    Kacperski J; Bazarsky A
    Curr Pain Headache Rep; 2017 Aug; 21(8):38. PubMed ID: 28779443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.
    Lewis SR; Pritchard MW; Schofield-Robinson OJ; Alderson P; Smith AF
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012584. PubMed ID: 30019463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mefloquine for preventing malaria during travel to endemic areas.
    Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches.
    Moja PL; Cusi C; Sterzi RR; Canepari C
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002919. PubMed ID: 16034880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study.
    Sakai F; Suzuki N; Ning X; Ishida M; Usuki C; Iba K; Isogai Y; Koga N
    Drug Saf; 2021 Dec; 44(12):1355-1364. PubMed ID: 34687446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in acute headache medication use and health care resource utilization: Results from a randomized, double-blind, placebo-controlled clinical trial evaluating galcanezumab in adults with treatment-resistant migraine (CONQUER).
    Ambrosini A; Estemalik E; Pascual J; Rettiganti M; Stroud C; Day K; Ford J
    J Manag Care Spec Pharm; 2022 Jun; 28(6):645-656. PubMed ID: 35451858
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.